| Stock (Symbol) | Stock Price | |
Herbalife (HLF) |
$46 |
|
| Data is as of | Expected to Report | Sector |
September 25, 2012 |
Oct 29 |
Food & Necessities |
| Sharek’s Take | ||
So now we sit and wait — and make a 2.6% yield. Nice. This stock is really undervalued and the company keeps performing above expectations. I think its only a matter of time before HLF goes back to $70. |
||
| One-Year Chart | ||
During the past two years, HLF’s P/E has fluctuated between 12 and 20. I got HLF when the P/E was 12 (stock was $27 afters splits). Then I said it was close to Fair Value when the P/E was 19 and the stock was $66. |
||
| Earnings Table | ||
Profits increased 25% last quarter as sales rose a respectable 17%.Herbalife whipped estimates by 14 cents last quarter — it did much better than the 8 cent beat 2QtrsAgo. It gets better… Annual Profit Estimates continue to rise — each year’s rose around a quarter. Management said there si increasing demand in China. This showing should have silenced critics. Quarterly estimates increased and I think these will get beat. HLF should grow profits 25% for the foreseeable future. |
||
| Fair Value | ||
This stock has healthy upside — this one of my most attractive investments. |
||
| Ten-Year Chart | ||
Profit growth is expected to clock in at 20% this year, solid for a stock with a 12 P/E. That number is up from 14% last quarter. 25% growth is attainable. HLF needs to fill that gap down — and it has what it takes to do so. I can feel a move to $70 coming. |
||
| Power Ranking | Bottom Line | |
Growth Portfolio
10 of 16 |
Investors are fearful Herbalife’s business model is comparable to a pyramid scheme. If true, this would be bad for its business in China. But China doesn’t have a problem with HLF’s sales practices – neither does the SEC which did a review in 2007. Meanwhile business is strong. I’m a believer that HLF will rebound, and would be a buyer here. |
|
Aggressive Growth Portfolio
8 of 8 |
||

During the past two years,
Profits increased 25% last quarter as sales rose a respectable 17%.
This stock has healthy upside — this one of my most attractive investments.
Profit growth is expected to clock in at 20% this year, solid for a stock with a 12 P/E. That number is up from 14% last quarter. 25% growth is attainable.